Related Experiment Video

Updated: May 30, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Prostaglandin E2 regulates renal cell carcinoma invasion through the EP4 receptor-Rap GTPase signal transduction

Juanjuan Wu1, Yushan Zhang, Nicole Frilot

  • 1Department of Pathology, Georgia Health Sciences University, Augusta, Georgia 30912, USA.

The Journal of Biological Chemistry
|August 12, 2011
PubMed

Insights

Prostaglandin E2 promotes kidney cancer invasion via EP4 and Rap signaling. Inhibiting EP4 or restoring Rap1GAP may offer new treatment strategies for advanced kidney cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • While early-stage kidney cancer prognosis has improved, treatment options for advanced and metastatic disease remain limited.
  • Understanding the molecular drivers of cancer invasion and metastasis is crucial for developing effective therapies.
  • Prostaglandin E2 (PGE2), a pro-inflammatory mediator, is implicated in cancer initiation and progression through G protein-coupled receptors (GPCRs).

Purpose of the Study:

  • To elucidate the molecular mechanisms by which prostaglandin E2 (PGE2) contributes to renal cancer cell invasion.
  • To investigate the role of the EP4 receptor and small GTPase Rap in PGE2-mediated kidney cancer cell invasion.
  • To explore the therapeutic potential of targeting the EP4/Rap signaling pathway for controlling kidney cancer progression.

Main Methods:

  • Investigated the signal transduction pathway involving EP4 and small GTPase Rap in renal cancer cells.
  • Utilized Rap1GAP to inactivate Rap signaling and EP4 antagonists or shRNA to inhibit EP4 signaling.
  • Compared EP4 and Rap1GAP expression levels in human malignant versus benign kidney tissue samples.

Main Results:

  • Prostaglandin E2 (PGE2) was found to promote renal cancer cell invasion through a pathway involving EP4 and Rap signaling.
  • Inhibition of EP4 signaling (using antagonists or shRNA) or inactivation of Rap signaling (using Rap1GAP) significantly reduced kidney cancer cell invasion.
  • Human kidney cancer tissues exhibited increased EP4 expression and decreased Rap1GAP expression compared to benign tissues.

Conclusions:

  • Targeted inhibition of EP4 signaling represents a potential therapeutic strategy to impede kidney cancer cell invasion.
  • Restoring Rap1GAP expression could be a novel approach to control the progression of kidney cancer.
  • The EP4/Rap signaling axis is a critical pathway in kidney cancer metastasis, offering new avenues for treatment development.

More Related Videos

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...